Leica Biosystems Nussloch

Leica Biosystems is a global leader in workflow solutions and automation for anatomical pathology and cancer diagnostics. The company provides a comprehensive range of products for each step in the pathology process, from sample preparation and staining to digital pathology and reporting. Headquartered in Nussloch, Germany, the company's portfolio includes industry-standard microtomes, tissue processors, and the Bond line of automated immunohistochemistry and in situ hybridization stainers. Leica Biosystems focuses on improving diagnostic precision and laboratory efficiency to support clinicians in making critical treatment decisions for cancer patients. Through its Aperio digital pathology business, the company also leads in the digitization of pathology workflows and image analysis. Their solutions are utilized in clinical laboratories and research institutions worldwide to advance the field of precision medicine.